Corsicana & Co. Novartis Ag Transaction History
Corsicana & Co.
- $119 Million
- Q3 2022
A detailed history of Corsicana & Co. transactions in Novartis Ag stock. As of the latest transaction made, Corsicana & Co. holds 16 shares of NVS stock, worth $1,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$1,749
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,433Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.33 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$811 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$810 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$650 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...